계명대학교 의학도서관 Repository

A Case of Patient with Lung Adenocarcinoma with Double Rare EGFR Mutation of G719C and L861Q

Metadata Downloads
Author(s)
Jin Tak YunGi Jun KimShin Young KimJoon Won JeongSuk Young ParkYoung Jun YangJi Chan Park
Journal Title
Keimyung Medical Journal
Issued Date
2014
Volume
33
Issue
2
Keyword
AdenocarcinomaEGFR tyrosine kinase inhibitorLung cancerMutation
Abstract
The vast majority of epidermal growth factor receptor (EGFR) gene mutations are detected in lung adenocarcinoma. EGFR mutations are the strongest predictor of response to EGFR tyrosine kinase inhibitor (TKI) treatment in patient with advanced non-small cell lung cancer. Of these, exon 19 deletions and exon 21 L858R point mutations account for more than 80% of mutations detected in tumor with EGFR mutations, which called classical EGFR mutations, and double mutations mainly composed of classical and uncommon EGFR mutations are reported to be present in 13% of total EGFR mutations. But there has been no report to date of patient with double mutation of TKI sensitive uncommon EGFR mutations (G719C and L861Q). We experienced a case of patient with lung adenocarcinoma with double mutation of G719C and L861Q, the first case on our literature review, and showing partial response to TKI treatment.
Alternative Title
A Case of Patient
with Lung Adenocarcinoma with Double Rare EGFR Mutation of G719C and L861Q
Publisher
Keimyung University School of Medicine
Citation
Jin Tak Yun et al. (2014). A Case of Patient with Lung Adenocarcinoma with Double Rare EGFR Mutation of G719C and L861Q. Keimyung Medical Journal, 33(2), 132–135.
Type
Article
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/15643
Appears in Collections:
2. Keimyung Medical Journal (계명의대 학술지) > 2014
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.